Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93124

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 02, 2023
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Pfizer Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-5534-24

D-0100-2024
Recall number
D-0100-2024
Initiated
October 02, 2023
Classification
Class I
Status
Terminated
Recalling firm
Pfizer Inc.
Quantity
24,900 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: identified as glass.

Code information

Lot#: GJ5007, Exp. 8/1/2024

Distribution pattern

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

drug · product 2 of 3

1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11

D-0101-2024
Recall number
D-0101-2024
Initiated
October 02, 2023
Classification
Class I
Status
Terminated
Recalling firm
Pfizer Inc.
Quantity
21,390 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: identified as glass.

Code information

Lot#: 42290DK, Exp. 6/1/2024

Distribution pattern

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

drug · product 3 of 3

2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11

D-0102-2024
Recall number
D-0102-2024
Initiated
October 02, 2023
Classification
Class I
Status
Terminated
Recalling firm
Pfizer Inc.
Quantity
3,200 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: identified as glass.

Code information

Lot#: GH6567, Exp. 7/1/2024

Distribution pattern

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

Field note

Send feedback

We'll only use this to respond to your feedback.